BSD Medical's Cancer Treatment Systems Get a Proposed 86% Reimbursement Boost

Date : 08/07/2007 @ 8:05AM
Source : PR Newswire
Stock : Bsd Medical Corp. (BSM)
Quote : 6.64  0.0 (0.00%) @ 3:22AM
<< BackQuote Chart Financials

 



BSD Medical's Cancer Treatment Systems Get a Proposed 86% Reimbursement Boost

SALT LAKE CITY, Aug. 7 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today reported that the Centers for Medicare and Medicaid Services (CMS) has proposed an approximate 86% increase in the reimbursement rate for all of the CMS codes applicable to the use of BSD cancer treatment systems for hospital outpatient procedures, which constitute the majority usage for BSD's cancer systems. Increases ranging from 14-44% have also been proposed for freestanding clinics (each code for freestanding clinics has a different value). CMS reimbursement rates generally set the standard for the payment schedules used by commercial insurance carriers as well.

The new proposed reimbursement rates will be finalized this November and become effective January 1, 2008. BSD considers this increase in reimbursement a major step forward in its ongoing effort to commercialize its cancer therapy systems, increasing the financial incentive for hospitals to adapt to more effective cancer treatment modalities.

About BSD Medical

BSD Medical Corp. is the leading developer of systems used to deliver hyperthermia therapy for the treatment of cancer. Hyperthermia therapy is used to kill cancer directly and increase the effectiveness of companion radiation treatments. Research has also shown promising results from the use of hyperthermia therapy in combination with chemotherapy, and for tumor reduction prior to surgery. For further information visit BSD Medical's website at http://www.bsdmedical.com/ or BSD's patient website at http://www.treatwithheat.com/.

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

DATASOURCE: BSD Medical Corp.

CONTACT: Hyrum A. Mead of BSD Medical Corp., +1-801-972-5555,

+1-801-972-5930 fax,

Web site: http://www.bsdmedical.com/

http://www.treatwithheat.com/

<< Back


Bsd Medical Corp. Historical Chart Bsd Medical Corp. Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
30 site:2us 081014 03:22 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )